ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immunocell Therapy Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-1O13776
Home | Market Reports | Health| Health Conditions| Cancer
Global Immunocell Therapy Market Research Report 2023
BUY CHAPTERS

Global Immunocell Therapy Market Insights, Forecast to 2030

Code: QYRE-Auto-1O13776
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Novartis
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)

Immunocell Therapy Market Size

The global Immunocell Therapy market is projected to grow from US$ 2120 million in 2024 to US$ 4413.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period.

Immunocell Therapy Market

Immunocell Therapy Market

Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
Market Analysis and Insights: Global Immunocell Therapy Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Immunocell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunocell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunocell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunocell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunocell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunocell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Immunocell Therapy Market Report

Report Metric Details
Report Name Immunocell Therapy Market
Accounted market size in 2024 US$ 2120 million
Forecasted market size in 2030 US$ 4413.7 million
CAGR 13.0
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Immunocell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Immunocell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunocell Therapy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Immunocell Therapy Market growing?

Ans: The Immunocell Therapy Market witnessing a CAGR of 13.0 during the forecast period 2025-2030.

What is the Immunocell Therapy Market size in 2030?

Ans: The Immunocell Therapy Market size in 2030 will be US$ 4413.7 million.

Who are the main players in the Immunocell Therapy Market report?

Ans: The main players in the Immunocell Therapy Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)

What are the Application segmentation covered in the Immunocell Therapy Market report?

Ans: The Applications covered in the Immunocell Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Immunocell Therapy Market report?

Ans: The Types covered in the Immunocell Therapy Market report are Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy, Others

Recommended Reports

Immunotherapy & Cell Therapy

Cancer & Lymphoma Treatment

Immunological Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2019-2030)
2.2 Global Immunocell Therapy Growth Trends by Region
2.2.1 Immunocell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunocell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Immunocell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Immunocell Therapy Market Dynamics
2.3.1 Immunocell Therapy Industry Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immunocell Therapy by Players
3.1.1 Global Immunocell Therapy Revenue by Players (2019-2024)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immunocell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2023
3.5 Global Key Players of Immunocell Therapy Head office and Area Served
3.6 Global Key Players of Immunocell Therapy, Product and Application
3.7 Global Key Players of Immunocell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2025-2030)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunocell Therapy Market Size (2019-2030)
6.2 North America Immunocell Therapy Market Size by Type
6.2.1 North America Immunocell Therapy Market Size by Type (2019-2024)
6.2.2 North America Immunocell Therapy Market Size by Type (2025-2030)
6.2.3 North America Immunocell Therapy Market Share by Type (2019-2030)
6.3 North America Immunocell Therapy Market Size by Application
6.3.1 North America Immunocell Therapy Market Size by Application (2019-2024)
6.3.2 North America Immunocell Therapy Market Size by Application (2025-2030)
6.3.3 North America Immunocell Therapy Market Share by Application (2019-2030)
6.4 North America Immunocell Therapy Market Size by Country
6.4.1 North America Immunocell Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Immunocell Therapy Market Size by Country (2019-2024)
6.4.3 North America Immunocell Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2019-2030)
7.2 Europe Immunocell Therapy Market Size by Type
7.2.1 Europe Immunocell Therapy Market Size by Type (2019-2024)
7.2.2 Europe Immunocell Therapy Market Size by Type (2025-2030)
7.2.3 Europe Immunocell Therapy Market Share by Type (2019-2030)
7.3 Europe Immunocell Therapy Market Size by Application
7.3.1 Europe Immunocell Therapy Market Size by Application (2019-2024)
7.3.2 Europe Immunocell Therapy Market Size by Application (2025-2030)
7.3.3 Europe Immunocell Therapy Market Share by Application (2019-2030)
7.4 Europe Immunocell Therapy Market Size by Country
7.4.1 Europe Immunocell Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Immunocell Therapy Market Size by Country (2019-2024)
7.4.3 Europe Immunocell Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immunocell Therapy Market Size (2019-2030)
8.2 China Immunocell Therapy Market Size by Type
8.2.1 China Immunocell Therapy Market Size by Type (2019-2024)
8.2.2 China Immunocell Therapy Market Size by Type (2025-2030)
8.2.3 China Immunocell Therapy Market Share by Type (2019-2030)
8.3 China Immunocell Therapy Market Size by Application
8.3.1 China Immunocell Therapy Market Size by Application (2019-2024)
8.3.2 China Immunocell Therapy Market Size by Application (2025-2030)
8.3.3 China Immunocell Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Immunocell Therapy Market Size (2019-2030)
9.2 Asia Immunocell Therapy Market Size by Type
9.2.1 Asia Immunocell Therapy Market Size by Type (2019-2024)
9.2.2 Asia Immunocell Therapy Market Size by Type (2025-2030)
9.2.3 Asia Immunocell Therapy Market Share by Type (2019-2030)
9.3 Asia Immunocell Therapy Market Size by Application
9.3.1 Asia Immunocell Therapy Market Size by Application (2019-2024)
9.3.2 Asia Immunocell Therapy Market Size by Application (2025-2030)
9.3.3 Asia Immunocell Therapy Market Share by Application (2019-2030)
9.4 Asia Immunocell Therapy Market Size by Region
9.4.1 Asia Immunocell Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Immunocell Therapy Market Size by Region (2019-2024)
9.4.3 Asia Immunocell Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immunocell Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Immunocell Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Immunocell Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Immunocell Therapy Introduction
11.1.4 Novartis Revenue in Immunocell Therapy Business (2019-2024)
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Immunocell Therapy Introduction
11.2.4 Gilead Sciences Revenue in Immunocell Therapy Business (2019-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immunocell Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Immunocell Therapy Introduction
11.4.4 J & J Revenue in Immunocell Therapy Business (2019-2024)
11.4.5 J & J Recent Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Immunocell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Immunocell Therapy Business (2019-2024)
11.5.5 JW Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Immunocell Therapy Introduction
11.6.4 FOSUNKite Revenue in Immunocell Therapy Business (2019-2024)
11.6.5 FOSUNKite Recent Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Details
11.8.2 Autolus Therapeutics(Pipeline) Business Overview
11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Introduction
11.8.4 Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.8.5 Autolus Therapeutics(Pipeline) Recent Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Details
11.9.2 Sorrento Therapeutics(Pipeline) Business Overview
11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Introduction
11.9.4 Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Details
11.10.2 Mustang Bio(Pipeline) Business Overview
11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Introduction
11.10.4 Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.10.5 Mustang Bio(Pipeline) Recent Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Details
11.11.2 Bluebird Bio(Pipeline) Business Overview
11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Introduction
11.11.4 Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.11.5 Bluebird Bio(Pipeline) Recent Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Details
11.12.2 Cellectis(Pipeline) Business Overview
11.12.3 Cellectis(Pipeline) Immunocell Therapy Introduction
11.12.4 Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.12.5 Cellectis(Pipeline) Recent Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Details
11.13.2 Allogene Therapeutics(Pipeline) Business Overview
11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Introduction
11.13.4 Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.13.5 Allogene Therapeutics(Pipeline) Recent Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Details
11.14.2 Celyad(Pipeline) Business Overview
11.14.3 Celyad(Pipeline) Immunocell Therapy Introduction
11.14.4 Celyad(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)
11.14.5 Celyad(Pipeline) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Gilead Sciences
Novartis
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
List of Tables
    Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
    Table 3. Key Players of Natural Killer (NK) Cell Therapy
    Table 4. Key Players of Others
    Table 5. Global Immunocell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Immunocell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Immunocell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Immunocell Therapy Market Share by Region (2019-2024)
    Table 9. Global Immunocell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Immunocell Therapy Market Share by Region (2025-2030)
    Table 11. Immunocell Therapy Market Trends
    Table 12. Immunocell Therapy Market Drivers
    Table 13. Immunocell Therapy Market Challenges
    Table 14. Immunocell Therapy Market Restraints
    Table 15. Global Immunocell Therapy Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Immunocell Therapy Revenue Share by Players (2019-2024)
    Table 17. Global Top Immunocell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2023)
    Table 18. Global Immunocell Therapy Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Immunocell Therapy, Headquarters and Area Served
    Table 21. Global Key Players of Immunocell Therapy, Product and Application
    Table 22. Global Key Players of Immunocell Therapy, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Immunocell Therapy Revenue Market Share by Type (2019-2024)
    Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Immunocell Therapy Revenue Market Share by Type (2025-2030)
    Table 28. Global Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Immunocell Therapy Revenue Share by Application (2019-2024)
    Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Immunocell Therapy Revenue Share by Application (2025-2030)
    Table 32. North America Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Immunocell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Immunocell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Immunocell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Immunocell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Immunocell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Immunocell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Immunocell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Immunocell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Immunocell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Immunocell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Immunocell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Immunocell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Immunocell Therapy Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Immunocell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Novartis Company Details
    Table 65. Novartis Business Overview
    Table 66. Novartis Immunocell Therapy Product
    Table 67. Novartis Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 68. Novartis Recent Developments
    Table 69. Gilead Sciences Company Details
    Table 70. Gilead Sciences Business Overview
    Table 71. Gilead Sciences Immunocell Therapy Product
    Table 72. Gilead Sciences Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 73. Gilead Sciences Recent Developments
    Table 74. Bristol-Myers Squibb Company Details
    Table 75. Bristol-Myers Squibb Business Overview
    Table 76. Bristol-Myers Squibb Immunocell Therapy Product
    Table 77. Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 78. Bristol-Myers Squibb Recent Developments
    Table 79. J & J Company Details
    Table 80. J & J Business Overview
    Table 81. J & J Immunocell Therapy Product
    Table 82. J & J Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 83. J & J Recent Developments
    Table 84. JW Therapeutics Company Details
    Table 85. JW Therapeutics Business Overview
    Table 86. JW Therapeutics Immunocell Therapy Product
    Table 87. JW Therapeutics Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 88. JW Therapeutics Recent Developments
    Table 89. FOSUNKite Company Details
    Table 90. FOSUNKite Business Overview
    Table 91. FOSUNKite Immunocell Therapy Product
    Table 92. FOSUNKite Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 93. FOSUNKite Recent Developments
    Table 94. CARsgen Therapeutics (Pipeline) Company Details
    Table 95. CARsgen Therapeutics (Pipeline) Business Overview
    Table 96. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product
    Table 97. CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 98. CARsgen Therapeutics (Pipeline) Recent Developments
    Table 99. Autolus Therapeutics(Pipeline) Company Details
    Table 100. Autolus Therapeutics(Pipeline) Business Overview
    Table 101. Autolus Therapeutics(Pipeline) Immunocell Therapy Product
    Table 102. Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 103. Autolus Therapeutics(Pipeline) Recent Developments
    Table 104. Sorrento Therapeutics(Pipeline) Company Details
    Table 105. Sorrento Therapeutics(Pipeline) Business Overview
    Table 106. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product
    Table 107. Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 108. Sorrento Therapeutics(Pipeline) Recent Developments
    Table 109. Mustang Bio(Pipeline) Company Details
    Table 110. Mustang Bio(Pipeline) Business Overview
    Table 111. Mustang Bio(Pipeline) Immunocell Therapy Product
    Table 112. Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 113. Mustang Bio(Pipeline) Recent Developments
    Table 114. Bluebird Bio(Pipeline) Company Details
    Table 115. Bluebird Bio(Pipeline) Business Overview
    Table 116. Bluebird Bio(Pipeline) Immunocell Therapy Product
    Table 117. Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 118. Bluebird Bio(Pipeline) Recent Developments
    Table 119. Cellectis(Pipeline) Company Details
    Table 120. Cellectis(Pipeline) Business Overview
    Table 121. Cellectis(Pipeline) Immunocell Therapy Product
    Table 122. Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 123. Cellectis(Pipeline) Recent Developments
    Table 124. Allogene Therapeutics(Pipeline) Company Details
    Table 125. Allogene Therapeutics(Pipeline) Business Overview
    Table 126. Allogene Therapeutics(Pipeline) Immunocell Therapy Product
    Table 127. Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 128. Allogene Therapeutics(Pipeline) Recent Developments
    Table 129. Celyad(Pipeline) Company Details
    Table 130. Celyad(Pipeline) Business Overview
    Table 131. Celyad(Pipeline) Immunocell Therapy Product
    Table 132. Celyad(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)
    Table 133. Celyad(Pipeline) Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunocell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Immunocell Therapy Market Share by Type: 2023 VS 2030
    Figure 3. Chimeric Antigen Receptor (CAR) T Cell Therapy Features
    Figure 4. Natural Killer (NK) Cell Therapy Features
    Figure 5. Others Features
    Figure 6. Global Immunocell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Immunocell Therapy Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Immunocell Therapy Report Years Considered
    Figure 12. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Immunocell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Immunocell Therapy Market Share by Region: 2023 VS 2030
    Figure 15. Global Immunocell Therapy Market Share by Players in 2023
    Figure 16. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2023
    Figure 18. North America Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Immunocell Therapy Market Share by Type (2019-2030)
    Figure 20. North America Immunocell Therapy Market Share by Application (2019-2030)
    Figure 21. North America Immunocell Therapy Market Share by Country (2019-2030)
    Figure 22. United States Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Immunocell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Immunocell Therapy Market Share by Type (2019-2030)
    Figure 26. Europe Immunocell Therapy Market Share by Application (2019-2030)
    Figure 27. Europe Immunocell Therapy Market Share by Country (2019-2030)
    Figure 28. Germany Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Immunocell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Immunocell Therapy Market Share by Type (2019-2030)
    Figure 36. China Immunocell Therapy Market Share by Application (2019-2030)
    Figure 37. Asia Immunocell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Immunocell Therapy Market Share by Type (2019-2030)
    Figure 39. Asia Immunocell Therapy Market Share by Application (2019-2030)
    Figure 40. Asia Immunocell Therapy Market Share by Region (2019-2030)
    Figure 41. Japan Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Immunocell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Immunocell Therapy Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Immunocell Therapy Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Immunocell Therapy Market Share by Country (2019-2030)
    Figure 51. Brazil Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Novartis Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 58. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 60. J & J Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 61. JW Therapeutics Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 62. FOSUNKite Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 63. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 64. Autolus Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 65. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 66. Mustang Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 67. Bluebird Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 68. Cellectis(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 69. Allogene Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 70. Celyad(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Immuno oncology Therapy Market Insights Forecast to 2030
Global Cancer Immunotherapy Market Insights Forecast to 2030
Global Adoptive Cell Therapy Market Insights Forecast to 2030
Global NK Cell Therapy Market Insights Forecast to 2030
Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Cell Therapy Market Research Report 2024
Global Immunotherapeutic Drugs Market Insights Forecast to 2030
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Global Cancer Immunotherapies Market Insights Forecast to 2030
Global Tumor Immune Cell Therapy Market Research Report 2024
Global Immunotherapy Drugs Market Research Report 2024
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global Cell Therapy Market Insights Forecast to 2030
Global Cancer Immunosuppressant Treatment Market Research Report 2024
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Global Cancer Immunotherapy Drugs Market Research Report 2024
Global T Cell Immunotherapy Market Research Report 2025
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Immunotherapy Platform Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions